Hepatitis C Hepatitis C  By 2018, twelve countries are on track to achieve HCV elimination.  While antiviral agents will curb new infections, it is less clear whether they impact overall deaths and morbidity.  Furthermore, for them to be effective, people need to be aware of their infection â€“ it is estimated that worldwide only 20% of infected people are aware of their infection . In the mid-1970s, Harvey J.  Alter, Chief of the Infectious Disease Section in the Department of Transfusion Medicine at the National Institutes of Health, and his research team demonstrated how most post-transfusion hepatitis cases were not due to hepatitis A or B viruses.  Despite this discovery, international research efforts to identify the virus, initially called non-A, non-B hepatitis , failed for the next decade.  In 1987, Michael Houghton, Qui-Lim Choo, and George Kuo at Chiron Corporation, collaborating with Daniel W Hepatitis C Hepatitis C